InvestorsHub Logo
Followers 42
Posts 12476
Boards Moderated 0
Alias Born 11/18/2016

Re: None

Friday, 12/23/2016 9:30:03 AM

Friday, December 23, 2016 9:30:03 AM

Post# of 108192
The repeated blaming of the CEO for the share price gives credence to the false premise that there is a legitimate reason for the suppressed share price. Period. None of the tutes, mm's and shorts give a rat's behind what the CEO did in 2014, or that management issued themselves a few hundred thousand options. Management has no control of the share price, all they can do is progress the vaccine development, which they are doing. If someone wants to replace some of the dead wood directors I would not complain, but to say that their presence on the board is a reason to devalue the stock is just nonsense. Same with the complaints about the CEO. Gee, he raises necessary cash and grants management stock options. What a radical agenda for a clinical biotech.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News